702 related articles for article (PubMed ID: 27067875)
1. EPICO 3.0. Antifungal prophylaxis in solid organ transplant recipients.
Zaragoza R; Aguado JM; Ferrer R; Rodríguez AH; Maseda E; Llinares P; Grau S; Muñoz P; Fortún J; Bouzada M; Pozo JC; León R;
Rev Iberoam Micol; 2016; 33(4):187-195. PubMed ID: 27067875
[TBL] [Abstract][Full Text] [Related]
2. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
[TBL] [Abstract][Full Text] [Related]
3. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
4. EPICO 3.0. Recommendations on invasive candidiasis in patients with complicated intra-abdominal infection and surgical patients with ICU extended stay.
Maseda E; Rodríguez AH; Aguilar G; Pemán J; Zaragoza R; Ferrer R; Llinares P; Grau S;
Rev Iberoam Micol; 2016; 33(4):196-205. PubMed ID: 27422492
[TBL] [Abstract][Full Text] [Related]
5. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
[TBL] [Abstract][Full Text] [Related]
6. Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3):135-49. PubMed ID: 23727234
[TBL] [Abstract][Full Text] [Related]
7. [Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3 Suppl 1):135-49. PubMed ID: 23764554
[TBL] [Abstract][Full Text] [Related]
8. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non- neutropenic critically ill adult patients.
Epico Project Group
Rev Esp Quimioter; 2013 Jun; 26(2):131-50. PubMed ID: 23817652
[TBL] [Abstract][Full Text] [Related]
9. EPICO 3.0. Management of non-neutropenic patients in medical wards.
Ferrer R; Zaragoza R; Rodríguez AH; Maseda E; Llinares P; Grau S; Álvarez-Lerma F; Quindós G; Salavert M; Huarte R;
Rev Iberoam Micol; 2016; 33(4):216-223. PubMed ID: 27769740
[TBL] [Abstract][Full Text] [Related]
10. ÉPICO project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Esp Anestesiol Reanim; 2013; 60(7):e1-e18. PubMed ID: 23911095
[TBL] [Abstract][Full Text] [Related]
11. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
12. EPICO 4.0. 'Total quality' in the management of invasive candidiasis in critically ill patients by analysing the integrated process.
Zaragoza R; Ferrer R; Llinares P; Maseda E; Rodríguez A; Grau S; Quindós G;
Rev Iberoam Micol; 2017; 34(3):143-157. PubMed ID: 28734773
[TBL] [Abstract][Full Text] [Related]
13. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
Playford EG; Webster AC; Sorell TC; Craig JC
Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients].
López-Medrano F; Díaz-Pedroche C; Lumbreras C; Aguado JM
Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227
[TBL] [Abstract][Full Text] [Related]
15. [Prophylaxis against fungal infections in solid organ and hematopoietic stem cells transplantation].
Rabagliati R; Santolaya ME
Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S11-8. PubMed ID: 23282550
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.
Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Singh N
Am J Transplant; 2014 Dec; 14(12):2758-64. PubMed ID: 25376267
[TBL] [Abstract][Full Text] [Related]
17. Antifungal prophylaxis in solid organ transplant recipients.
Brizendine KD; Vishin S; Baddley JW
Expert Rev Anti Infect Ther; 2011 May; 9(5):571-81. PubMed ID: 21609268
[TBL] [Abstract][Full Text] [Related]
18. Role of new antifungal agents in prophylaxis of mycoses in high risk patients.
van Burik JA
Curr Opin Infect Dis; 2005 Dec; 18(6):479-83. PubMed ID: 16258319
[TBL] [Abstract][Full Text] [Related]
19. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
Biancofiore G; Bindi ML; Baldassarri R; Romanelli AM; Catalano G; Filipponi F; Vagelli A; Mosca F
Transpl Int; 2002 Jul; 15(7):341-7. PubMed ID: 12122510
[TBL] [Abstract][Full Text] [Related]
20. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
